Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ASH 2016 Preview: Don't Miss These 10 Data Presentations

Executive Summary

A CAR-T late breaker from Kite Pharma and sickle cell disease updates from recently acquired Oklahoma biotech, Selxys, lead Scrip's handpicked top 10 data presentations you shouldn't miss at this year's American Society for Hematology annual meeting, held in San Diego, Dec. 2-6.

Advertisement

Related Content

Sickle Cell Data Show Value Of Novartis’s Recently Acquired SEG101
Novartis, Kite Neck-And-Neck In CAR-T Race; Deaths Keep Juno In Third Place
New Drugs Aim To Move Needle In Tough-to-Treat Acute Myeloid Leukemia
No Hat Trick For Roche's Gazyva In Lymphoma
New Market For Genentech's Gazyva: Follicular Lymphoma
Venetoclax And Other New Kids On The Block Shine At ASH

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC097729

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel